Ratings Acen Corporation Philippines S.E.

Equities

ACENA

PH0000057408

End-of-day quote Philippines S.E. 03:30:00 19/06/2024 am IST 5-day change 1st Jan Change
1,015 PHP 0.00% Intraday chart for Acen Corporation 0.00% -3.33%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Analyst opinion has improved significantly over the past four months.

Weaknesses

  • One of the major weak points of the company is its financial situation.
  • Based on current prices, the company has particularly high valuation levels.
  • The company is not the most generous with respect to shareholders' compensation.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Independent Power Producers

1st Jan change Capi. Investor Rating ESG Refinitiv
-3.33% 3.23B -
+16.50% 43B
B
+40.66% 34.62B -
C
+32.63% 18.01B
B-
+52.17% 14.29B
B
+82.34% 6.83B
D-
+36.59% 6.42B
C+
+37.59% 5.28B
C
-6.71% 3.92B -
C
+33.62% 3.91B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality